Neuronetics Inc. (STIM)
4.68
-0.18 (-3.70%)
At close: Mar 24, 2025, 3:59 PM
4.76
1.62%
After-hours: Mar 24, 2025, 07:39 PM EDT
-3.70% (1D)
| Bid | 4.66 |
| Market Cap | 187.72M |
| Revenue (ttm) | 81.82M |
| Net Income (ttm) | -47.2M |
| EPS (ttm) | -1.37 |
| PE Ratio (ttm) | -3.42 |
| Forward PE | -4.28 |
| Analyst | Buy |
| Ask | 4.86 |
| Volume | 998,686 |
| Avg. Volume (20D) | 1,557,110 |
| Open | 4.96 |
| Previous Close | 4.86 |
| Day's Range | 4.65 - 5.05 |
| 52-Week Range | 0.52 - 5.92 |
| Beta | 2.07 |
About STIM
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, ...
Industry Medical - Diagnostics & Research
Sector Healthcare
IPO Date Jun 28, 2018
Employees 203
Stock Exchange NASDAQ
Ticker Symbol STIM
Website https://www.neurostar.com
Analyst Forecast
According to 4 analyst ratings, the average rating for STIM stock is "Buy." The 12-month stock price forecast is $7, which is an increase of 49.41% from the latest price.
Stock ForecastsNext Earnings Release
Neuronetics Inc. is scheduled to release its earnings on May 6, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 weeks ago
+7.11%
Neuronetics shares are trading higher after Citize...
Unlock content with
Pro Subscription
1 month ago
-13.76%
Neuronetics shares are trading lower after the company announced the pricing of a $18 million public offering of 8 million shares at $2.25 per share.
